These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22815097)

  • 21. Comparison of Pharmacy Claims and Electronic Pill Bottles for Measurement of Medication Adherence Among Myocardial Infarction Patients.
    Mehta SJ; Asch DA; Troxel AB; Lim R; Lewey J; Wang W; Zhu J; Norton L; Marcus N; Volpp KG
    Med Care; 2019 Feb; 57(2):e9-e14. PubMed ID: 30045159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and incidence of type 1 diabetes in Ireland: a retrospective cross-sectional study using a national pharmacy claims data from 2016.
    Gajewska KA; Biesma R; Sreenan S; Bennett K
    BMJ Open; 2020 Apr; 10(4):e032916. PubMed ID: 32312725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The epidemiology of prescriptions abandoned at the pharmacy.
    Shrank WH; Choudhry NK; Fischer MA; Avorn J; Powell M; Schneeweiss S; Liberman JN; Dollear T; Brennan TA; Brookhart MA
    Ann Intern Med; 2010 Nov; 153(10):633-40. PubMed ID: 21079218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applicability of a new specialty pharmacy-reported measure describing completion of therapy for hepatitis C.
    Bolduc C; McCall K; Stickney K; Gelinas A; Levesque E
    J Manag Care Spec Pharm; 2021 Feb; 27(2):263-267. PubMed ID: 33506724
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.
    Cooke CE; Lee HY; Tong YP; Haines ST
    Curr Med Res Opin; 2010 Jan; 26(1):231-8. PubMed ID: 19921965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medication adherence and improved outcomes among patients with type 2 diabetes.
    Curtis SE; Boye KS; Lage MJ; Garcia-Perez LE
    Am J Manag Care; 2017 Jul; 23(7):e208-e214. PubMed ID: 28850793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of incident depression on medication adherence in patients with type 2 diabetes.
    Lunghi C; Zongo A; Moisan J; Grégoire JP; Guénette L
    Diabetes Metab; 2017 Dec; 43(6):521-528. PubMed ID: 28822618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship Between Medication Adherence and Distance to Dispensing Pharmacies and Prescribers Among an Urban Medicaid Population with Diabetes Mellitus.
    Syed ST; Sharp LK; Kim Y; Jentleson A; Lora CM; Touchette DR; Berbaum ML; Suda KJ; Gerber BS
    Pharmacotherapy; 2016 Jun; 36(6):590-7. PubMed ID: 27087250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
    Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
    J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geographic Variation in Antidiabetic Agent Adherence and Glycemic Control Among Patients with Type 2 Diabetes.
    Tan E; Yang W; Pang B; Dai M; Loh FE; Hogan P
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1195-202. PubMed ID: 26679968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
    Cheong C; Barner JC; Lawson KA; Johnsrud MT
    Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent).
    Kalsekar I; Sheehan C; Peak A
    Res Social Adm Pharm; 2007 Dec; 3(4):378-91. PubMed ID: 18082874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacy and medical claims data identified migraine sufferers with high specificity but modest sensitivity.
    Kolodner K; Lipton RB; Lafata JE; Leotta C; Liberman JN; Chee E; Moon C
    J Clin Epidemiol; 2004 Sep; 57(9):962-72. PubMed ID: 15504639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes.
    Yeaw J; Lee WC; Aagren M; Christensen T
    J Manag Care Pharm; 2012; 18(1):21-32. PubMed ID: 22235952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing adherence and persistence across 6 chronic medication classes.
    Yeaw J; Benner JS; Walt JG; Sian S; Smith DB
    J Manag Care Pharm; 2009; 15(9):728-40. PubMed ID: 19954264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dispensing channel and medication adherence: evidence across 3 therapy classes.
    Iyengar R; Henderson R; Visaria J; Glave Frazee S
    Am J Manag Care; 2013 Oct; 19(10):798-804. PubMed ID: 24304158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Store and prescription characteristics associated with primary medication nonadherence.
    Jackson TH; Bentley JP; McCaffrey DJ; Pace P; Holmes E; West-Strum D
    J Manag Care Spec Pharm; 2014 Aug; 20(8):824-32. PubMed ID: 25062076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of the Medication Possession Ratio to Modelling Decisions in Large Claims Databases.
    Bjarnadottir MV; Czerwinski D; Onukwugha E
    Pharmacoeconomics; 2018 Mar; 36(3):369-380. PubMed ID: 29230712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.